A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model

CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy

(2016) Ilya V. Ulasov et al.   Oncotarget

Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma

(2015) L. Soroceanu et al.   CANCER RESEARCH

Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact

(2015) O Fornara et al.   CELL DEATH AND DIFFERENTIATION

A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma

(2015) Julius W. Kim et al.   HUMAN GENE THERAPY

DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?

(2015) Thomas Niezold et al.   IMMUNOLOGY

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

(2015) Kylie M. Quinn et al.   JOURNAL OF CLINICAL INVESTIGATION

Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma

(2015) Mahua Dey et al.   JOURNAL OF IMMUNOLOGY

DEC205+Dendritic Cell–Targeted Tolerogenic Vaccination Promotes Immune Tolerance in Experimental Autoimmune Arthritis

(2015) Rachel Spiering et al.   JOURNAL OF IMMUNOLOGY

Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo

(2015) Jiangtao Ma et al.   PLoS Pathogens

Dendritic Cell-Based Vaccination in Cancer: Therapeutic Implications Emerging from Murine Models

(2015) Soledad Mac Keon et al.   Frontiers in Immunology

Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy

(2015) Ivy Wilkinson-Ryan et al.   PLoS One

Dendritic Cell-Based Vaccine for the Treatment of Malignant Glioma: A Systematic Review

(2014) Xuan Wang et al.   CANCER INVESTIGATION

Selective Uptake of Cylindrical Poly(2-Oxazoline) Brush-AntiDEC205 Antibody-OVA Antigen Conjugates into DEC-Positive Dendritic Cells and Subsequent T-Cell Activation

(2014) Jasmin Bühler et al.   CHEMISTRY-A EUROPEAN JOURNAL

The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery

(2014) Estrella Lopez-Gordo et al.   Expert Opinion on Drug Delivery

Therapeutic cell carriers: a potential road to cure glioma

(2014) Jacob S Young et al.   Expert Review of Neurotherapeutics

Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors

(2014) Estrella Lopez-Gordo et al.   HUMAN GENE THERAPY

Does the existence of HCMV components predict poor prognosis in glioma?

(2014) Daling Ding et al.   JOURNAL OF NEURO-ONCOLOGY

Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205

(2014) M. V. Dhodapkar et al.   Science Translational Medicine

Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme

(2014) Andrea Schuessler et al.   Frontiers in Oncology

Cytomegalovirus Contributes to Glioblastoma in the Context of Tumor Suppressor Mutations

(2013) R. L. Price et al.   CANCER RESEARCH

A Preclinical Evaluation of Neural Stem Cell–Based Cell Carrier for Targeted Antiglioma Oncolytic Virotherapy

(2013) Atique U. Ahmed et al.   JNCI-Journal of the National Cancer Institute

Valganciclovir in Patients with Glioblastoma

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer

(2013) Julius W. Kim et al.   PLoS One

Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity

(2013) Ines Matos et al.   PLoS One

Retargeting of gene expression using endothelium specific hexon modified adenoviral vector

(2013) Sergey A. Kaliberov et al.   VIROLOGY

Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera

(2013) Bin Yu et al.   VIROLOGY

Cross-dressed CD8 +/CD103+ dendritic cells prime CD8+ T cells following vaccination

(2012) L. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Adenovirus receptors: implications for targeting of viral vectors

(2012) Niklas Arnberg   TRENDS IN PHARMACOLOGICAL SCIENCES

Targeting Dendritic Cells in vivo for Cancer Therapy

(2012) Irina Caminschi et al.   Frontiers in Immunology

Multimerization of Adenovirus Serotype 3 Fiber Knob Domains Is Required for Efficient Binding of Virus to Desmoglein 2 and Subsequent Opening of Epithelial Junctions

(2011) H. Wang et al.   JOURNAL OF VIROLOGY

Targeting human dendritic cell subsets for improved vaccines

(2011) Hideki Ueno et al.   SEMINARS IN IMMUNOLOGY

Harnessing dendritic cells in cancer

(2011) Lionel Apetoh et al.   SEMINARS IN IMMUNOLOGY

Selective Transduction of Dendritic Cells in Human Lymph Nodes and Superior Induction of High-avidity Melanoma-reactive Cytotoxic T Cells by a CD40-targeted Adenovirus

(2010) Basav N. Hangalapura et al.   JOURNAL OF IMMUNOTHERAPY

Substitution of Adenovirus Serotype 3 Hexon onto a Serotype 5 Oncolytic Adenovirus Reduces Factor X Binding, Decreases Liver Tropism, and Improves Antitumor Efficacy

(2010) J. J. Short et al.   MOLECULAR CANCER THERAPEUTICS

Selective Transduction of Mature DC in Human Skin and Lymph Nodes by CD80/CD86-targeted Fiber-modified Adenovirus-5/3

(2009) Rieneke van de Ven et al.   JOURNAL OF IMMUNOTHERAPY

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

(2008) K. Hildner et al.   SCIENCE